Your browser doesn't support javascript.
loading
Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Williams, Kathryn H; Sullivan, David R; Nicholson, Geoffrey C; George, Jacob; Jenkins, Alicia J; Januszewski, Andrzej S; Gebski, Val J; Manning, Patrick; Tan, Yong Mong; Donoghoe, Mark W; Ehnholm, Christian; Young, Simon; O'Brien, Richard; Buizen, Luke; Twigg, Stephen M; Keech, Anthony C.
Afiliación
  • Williams KH; Sydney Medical School, University of Sydney, Sydney NSW, Australia; Royal Prince Alfred Hospital, Sydney NSW, Australia; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney NSW, Australia.
  • Sullivan DR; Royal Prince Alfred Hospital, Sydney NSW, Australia; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney NSW, Australia.
  • Nicholson GC; Rural Clinical School, University of Queensland, Brisbane QLD, Australia.
  • George J; Sydney Medical School, University of Sydney, Sydney NSW, Australia; Storr Liver Unit, Westmead Millennium Institute, Westmead Hospital, Sydney NSW, Australia.
  • Jenkins AJ; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney NSW, Australia.
  • Januszewski AS; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney NSW, Australia.
  • Gebski VJ; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney NSW, Australia.
  • Manning P; Department of Medical and Surgical Sciences, Dunedin School of Medicine, Dunedin, New Zealand.
  • Tan YM; Townsville Diabetes and Endocrine Unit, Townsville Hospital, Townsville QLD, Australia.
  • Donoghoe MW; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney NSW, Australia.
  • Ehnholm C; Biomedicum Helsinki, Helsinki, Finland.
  • Young S; Diabetes Clinic, Northshore Hospital, Auckland, New Zealand.
  • O'Brien R; Austin hospital, Melbourne VIC, Australia.
  • Buizen L; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney NSW, Australia.
  • Twigg SM; Sydney Medical School, University of Sydney, Sydney NSW, Australia; Royal Prince Alfred Hospital, Sydney NSW, Australia.
  • Keech AC; Royal Prince Alfred Hospital, Sydney NSW, Australia; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney NSW, Australia. Electronic address: fieldtrial@ctc.usyd.edu.au.
Metabolism ; 65(5): 783-793, 2016 May.
Article en En | MEDLINE | ID: mdl-27085785

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fenofibrato / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Angiopatías Diabéticas / Enfermedad del Hígado Graso no Alcohólico / Hígado / Hipolipemiantes Tipo de estudio: Clinical_trials / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa / Oceania Idioma: En Revista: Metabolism Año: 2016 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fenofibrato / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Angiopatías Diabéticas / Enfermedad del Hígado Graso no Alcohólico / Hígado / Hipolipemiantes Tipo de estudio: Clinical_trials / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa / Oceania Idioma: En Revista: Metabolism Año: 2016 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos